| Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group PY Wen, DR Macdonald, DA Reardon, TF Cloughesy, AG Sorensen, ... Journal of clinical oncology 28 (11), 1963-1972, 2010 | 4185 | 2010 |
| A randomized trial of bevacizumab for newly diagnosed glioblastoma MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ... New England Journal of Medicine 370 (8), 699-708, 2014 | 3082 | 2014 |
| Response assessment criteria for brain metastases: proposal from the RANO group NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ... The lancet oncology 16 (6), e270-e278, 2015 | 942 | 2015 |
| Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208, 2016 | 748 | 2016 |
| Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review L Rogers, I Barani, M Chamberlain, TJ Kaley, M McDermott, J Raizer, ... Journal of neurosurgery 122 (1), 4-23, 2015 | 717 | 2015 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ... Neuro-oncology 17 (9), 1188-1198, 2015 | 708 | 2015 |
| Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): An American Society for Radiation Oncology evidence-based guideline MN Tsao, D Rades, A Wirth, SS Lo, BL Danielson, LE Gaspar, ... Practical radiation oncology 2 (3), 210-225, 2012 | 690 | 2012 |
| Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas MJ van den Bent, JS Wefel, D Schiff, MJB Taphoorn, K Jaeckle, L Junck, ... The lancet oncology 12 (6), 583-593, 2011 | 642 | 2011 |
| Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma S Kunwar, S Chang, M Westphal, M Vogelbaum, J Sampson, G Barnett, ... Neuro-oncology 12 (8), 871-881, 2010 | 524 | 2010 |
| Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells SO Rahaman, PC Harbor, O Chernova, GH Barnett, MA Vogelbaum, ... Oncogene 21 (55), 8404-8413, 2002 | 489 | 2002 |
| Treatment for brain metastases: ASCO-SNO-ASTRO guideline MA Vogelbaum, PD Brown, H Messersmith, PK Brastianos, S Burri, ... Neuro-oncology 24 (3), 331-357, 2022 | 455 | 2022 |
| Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma MM Grabowski, PF Recinos, AS Nowacki, JL Schroeder, L Angelov, ... Journal of neurosurgery 121 (5), 1115-1123, 2014 | 442 | 2014 |
| Response assessment in neuro-oncology clinical trials PY Wen, SM Chang, MJ Van den Bent, MA Vogelbaum, DR Macdonald, ... Journal of Clinical Oncology 35 (21), 2439-2449, 2017 | 435 | 2017 |
| Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions AA Kanner, N Marchi, V Fazio, MR Mayberg, MT Koltz, V Siomin, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 417 | 2003 |
| Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma B Raychaudhuri, P Rayman, J Ireland, J Ko, B Rini, EC Borden, J Garcia, ... Neuro-oncology 13 (6), 591-599, 2011 | 401 | 2011 |
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 … MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ... The Lancet 390 (10103), 1645-1653, 2017 | 395 | 2017 |
| Poor drug distribution as a possible explanation for the results of the PRECISE trial JH Sampson, G Archer, C Pedain, E Wembacher-Schröder, M Westphal, ... Journal of neurosurgery 113 (2), 301-309, 2010 | 284 | 2010 |
| End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria MJ van den Bent, MA Vogelbaum, PY Wen, DR Macdonald, SM Chang Journal of Clinical Oncology 27 (18), 2905-2908, 2009 | 282 | 2009 |
| Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539 L Rogers, P Zhang, MA Vogelbaum, A Perry, LS Ashby, JM Modi, ... Journal of neurosurgery 129 (1), 35-47, 2017 | 279 | 2017 |
| Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin MA Vogelbaum, L Angelov, SY Lee, L Li, GH Barnett, JH Suh Journal of neurosurgery 104 (6), 907-912, 2006 | 272 | 2006 |
Gene BarnettCleveland ClinicEmail verificata su ccf.org